1. Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program. Issue 5 (31st July 2018) Authors: Rådholm, Karin; Figtree, Gemma; Perkovic, Vlado; Solomon, Scott D.; Mahaffey, Kenneth W.; de Zeeuw, Dick; Fulcher, Greg; Barrett, Terrance D.; Shaw, Wayne; Desai, Mehul; Matthews, David R.; Neal, Bruce Journal: Circulation Issue: Volume 138:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials. Issue 9 (September 2018) Authors: Perkovic, Vlado; de Zeeuw, Dick; Mahaffey, Kenneth W; Fulcher, Greg; Erondu, Ngozi; Shaw, Wayne; Barrett, Terrance D; Weidner-Wells, Michele; Deng, Hsiaowei; Matthews, David R; Neal, Bruce Journal: Lancet Issue: Volume 6:Issue 9(2018) Page Start: 691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Canagliflozin and Stroke in Type 2 Diabetes Mellitus: Results From the Randomized CANVAS Program Trials. Issue 2 (February 2019) Authors: Zhou, Zien; Lindley, Richard I.; Rådholm, Karin; Jenkins, Bronwyn; Watson, John; Perkovic, Vlado; Mahaffey, Kenneth W.; de Zeeuw, Dick; Fulcher, Greg; Shaw, Wayne; Oh, Richard; Desai, Mehul; Matthews, David R.; Neal, Bruce Journal: Stroke Issue: Volume 50:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study). Issue 4 (23rd January 2018) Authors: Mahaffey, Kenneth W.; Neal, Bruce; Perkovic, Vlado; de Zeeuw, Dick; Fulcher, Greg; Erondu, Ngozi; Shaw, Wayne; Fabbrini, Elisa; Sun, Tao; Li, Qiang; Desai, Mehul; Matthews, David R. Journal: Circulation Issue: Volume 137:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Canagliflozin: a sodium glucose co‐transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. Issue 1 (25th August 2015) Authors: Rosenthal, Norm; Meininger, Gary; Ways, Kirk; Polidori, David; Desai, Mehul; Qiu, Rong; Alba, Maria; Vercruysse, Frank; Balis, Dainius; Shaw, Wayne; Edwards, Robert; Bull, Scott; Di Prospero, Nicholas; Sha, Sue; Rothenberg, Paul; Canovatchel, William; Demarest, Keith Journal: Annals of the New York Academy of Sciences Issue: Volume 1358:Issue 1(2015) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program. Issue 4 (3rd January 2020) Authors: Ohkuma, Toshiaki; Van Gaal, Luc; Shaw, Wayne; Mahaffey, Kenneth W.; de Zeeuw, Dick; Matthews, David R.; Perkovic, Vlado; Neal, Bruce Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 4(2020) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial. Issue 4 (7th April 2021) Authors: Yu, Jie; Li, Jingwei; Leaver, Phillip J; Arnott, Clare; Huffman, Mark D; Udell, Jacob A; Perkovic, Vlado; Mahaffey, Kenneth W; de Zeeuw, Dick; Fulcher, Greg; Matthews, David R; Shaw, Wayne; Rosenthal, Norman; Neal, Bruce; Figtree, Gemma A Journal: Cardiovascular research Issue: Volume 118:Issue 4(2022) Page Start: 1103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis. Issue 3 (March 2016) Authors: Sinclair, Alan J.; Bode, Bruce; Harris, Stewart; Vijapurkar, Ujjwala; Shaw, Wayne; Desai, Mehul; Meininger, Gary Journal: Journal of the American Geriatrics Society Issue: Volume 64:Issue 3(2016:Mar.) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials. Issue 7 (3rd April 2017) Authors: Neal, Bruce; Perkovic, Vlado; Mahaffey, Kenneth W.; Fulcher, Greg; Erondu, Ngozi; Desai, Mehul; Shaw, Wayne; Law, Gordon; Walton, Marc K.; Rosenthal, Norm; de Zeeuw, Dick; Matthews, David R. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 7(2017) Page Start: 926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial. Issue 3 (25th January 2017) Authors: Neal, Bruce; Perkovic, Vlado; Matthews, David R.; Mahaffey, Kenneth W.; Fulcher, Greg; Meininger, Gary; Erondu, Ngozi; Desai, Mehul; Shaw, Wayne; Vercruysse, Frank; Yee, Jacqueline; Deng, Hsiaowei; de Zeeuw, Dick Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 3(2017) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗